trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone
-
![trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/3baac6583e654a7590852d61c1f724b2.png "trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone")
trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone
structure -
-
CAS No:
87152-97-4
-
Formula:
C27H33N5O3
-
Chemical Name:
trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone
-
Synonyms:
6-[4-[1-(trans-4-Benzyloxycyclohexyl)-1H-5-tetrazolyl]butoxy]-2-oxo-1,2,3,4-tetrahydroquinoline;trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone;2(1H)-Quinolinone, 3,4-dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-, trans- (9CI)
-
CAS No:
trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone Basic Attributes
475.58
475.25833993
DTXSID70534423
trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone Use and Manufacturing
2-Oxoquinoline derivative as blood platelet aggregation inhibitors. Intermediate of OPC-13013, a metabolite of Cilostazol
Computed Properties
Molecular Weight:475.6
XLogP3:4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:10
Exact Mass:475.25833993
Monoisotopic Mass:475.25833993
Topological Polar Surface Area:91.2
Heavy Atom Count:35
Complexity:653
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation